SEC Form 4 · accession 0001000229-17-000081
CORE LABORATORIES N V · CLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Scott Hill
Officer — Chief Accounting Officer
Period of report
Sep 1, 2017
Accepted (ET)
Sep 5, 2017 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000229
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Sep 1, 2017 | M | 125 | $0.00 | A | 9,306 | D | |
| Common Shares | Sep 1, 2017 | F | 35 | $89.59 | D | 9,271 | D | |
| Common Shares | holding | — | — | — | 59 | I | 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted SharesF1,F2 | $0.00 | Sep 1, 2017 | M | 125 | D | — | — | Common Shares | 125 | 609 | D |
Explanation of responses
- F1The Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the date of grant.
- F2Multiple restricted share grants are included in this total.